Can Hims Hold $45 Support and Rebuild Momentum?
$Hims & Hers Health Inc.(HIMS)$
$45.46 (+3.18%): First bounce attempt from a weak tape; $45 needs to hold to avoid a deeper fade toward $42
Market Recap (as of Oct 31, 2025):
Hims & Hers Health closed at $45.46 after trading $45.03–$47.24. Volume was ~4.1M vs ~28.7M avg (~0.14×), a light-participation day.
Shares are ~38% below the 52-wk high ($72.98; low $19.15). Overnight indication shows a modest bid near $46.90.
Technical Indicators Analysis:
RSI(14) ~40 (neutral-bearish) after a multi-week drift; MACD stays below zero and under its signal, though the histogram’s decline is slowing—early signs of downside exhaustion.
Price is hovering just above a minor horizontal shelf around $45; reclaiming $47–48 would be the first step to rebuild momentum.
Base case (1–3 weeks): chop with a slight upside bias if $45 holds; otherwise a quick check of $43–42 is on deck.
Support / Resistance: Support: $42 Resistance: $50/$67.33
Valuation and Trading Map:
TTM P/E ~57.5×; no dividend. Near-term plan: defend $45 → probe $47.5–$49.8.
A daily close > $50 would open $53–$55. A decisive break < $45 likely tests $43–$42 (gap/volume shelf) before stronger buyers show up.
Risk Statement:
Single-name momentum, sentiment around GLP-1/consumer-health categories, liquidity, and earnings/guidance can overwhelm technicals. This is technical commentary, not investment advice—use strict risk controls.
Data Source: Yahoo Finance & TradingView (daily/YTD, Oct 31, 2025). Prepared by Tiger Morning Brief | For internal use only.
For SG users only, a tool to boost your purchasing power and trading ideas with a Cash Boost Account!
Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here.
Other helpful links:
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
